MedTrace Logo

Antarctic Krill Oil for Knee Osteoarthritis Pain

NCT06880926 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2025-03-18

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effectiveness and safety of Antarctic Krill Oil (AKO) as a dietary supplement in managing pain associated with knee osteoarthritis (OA). The main questions it aims to answer are:

①Does AKO reduce daily pain intensity in participants with moderate knee OA?

②What adverse effects do participants experience when taking AKO?

Researchers will conduct a randomized, double-blind study comparing AKO to a placebo (identical appearance without active components) to assess:

* Changes in joint pain severity; ②Functional improvement in daily activities; ③Biochemical safety parameters,etc.

Conditions

  • Osteoarthritis (OA) of the Knee
  • Osteoarthritis Knee Pain

Interventions

DRUG

Krill oil

Antarctic krill oil was used for intervention in the experimental group.

DIETARY_SUPPLEMENT

Olive Oil

Olive oil was used for intervention in the placebo group.

Sponsors & Collaborators

  • Qilu Hospital of Shandong University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2026-02-28
Completion
2026-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06880926 on ClinicalTrials.gov